For the period ending October 3, Wal-Mart (WMT) same-store sales rose 1.4%. Total company revenue rose 10% for the period to $34.4 billion.
International sales were the big driver, moving up over 20% to $8.9 billion.
Commenting on its US sales, the company said for the five-week period, comparable store sales at the Wal-Mart Stores segment were driven by grocery and pharmacy. WMT marked the anniversary of its $4 generic prescription program with a national expansion of additional medications available for treating even more conditions.
During the September period, the United Kingdom, Brazil and China continued their recent positive performance. Sales throughout Brazil continue to be driven by a stronger price position, assortment that is customized to the local community and a recovery of disposable income. Macroeconomic factors continued to contribute to a slowdown in sales in Mexico.
WMT expects the comparable store sales of its U.S. operations for the October four-week reporting period to be between flat and 2 percent.
WMT shares were up over 4% in the pre-market
Douglas A. McIntyre